U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Tran K, Coyle K, Jabr MF, et al. Drugs for Pulmonary Arterial Hypertension: Comparative Efficacy, Safety, and Cost-Effectiveness [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Mar.

Cover of Drugs for Pulmonary Arterial Hypertension: Comparative Efficacy, Safety, and Cost-Effectiveness

Drugs for Pulmonary Arterial Hypertension: Comparative Efficacy, Safety, and Cost-Effectiveness [Internet].

Show details

APPENDIX 12COMPLETE RESULTS OF NETWORK META-ANALYSIS

Table 198. Meta-analysis Results of Clinical Worsening, Total Populations of All Studies (Random)

Table 199. Meta-analysis Results of Clinical Worsening, Total Populations of All Studies (Fixed)

Table 200. Meta-analysis Results of Clinical Worsening, Naive Populations of All Studies (Random)

Table 201. Meta-analysis Results of Clinical Worsening, Naive Populations of All Studies (Fixed)

Table 202. Meta-analysis Results of Clinical Worsening, Total Populations of All Studies; No Macitentan (Random)

Table 203. Meta-analysis Results of Clinical Worsening, Total Populations of All Studies; No Macitentan (Fixed)

Table 204. Meta-analysis Results of Clinical Worsening, Naive Populations of All Studies; No Macitentan (Random)

Table 205. Meta-analysis Results of Clinical Worsening, Naive Populations of All Studies; No Macitentan (Fixed)

Table 206. Meta-analysis Results of Functional Class Improvement, Total Populations of All Studies (Random)

Table 207. Meta-analysis Results of Functional Class Improvement, Total Populations of All Studies (Fixed)

Table 208. Meta-analysis Results of Functional Class Improvement, Naive Populations of All Studies (Random)

Table 209. Meta-analysis Results of FC Improvement, Naive Populations of All Studies (Fixed)

Table 210. Meta-analysis Results of Functional Class Improvement, Total Populations of All Studies; No Macitentan (Random)

Table 211. Meta-analysis Results of Functional Class Improvement, Total Populations of All Studies; No Macitentan (Fixed)

Table 212. Meta-analysis Results of Functional Class Worsening, Total Populations of All Studies (Random)

Table 213. Meta-analysis Results of Functional Class Worsening, Total Populations of All Studies (Fixed)

Table 214. Meta-analysis Results of Functional Class Worsening, Naive Populations of All Studies (Random)

Table 215. Meta-analysis Results of Functional Class Worsening, Naive Populations of All Studies (Fixed)

Table 216. Meta-analysis Results of Functional Class Worsening, Total Populations of All Studies; No Macitentan (Random)

Table 217. Meta-analysis Results of Functional Class Worsening, Total Populations of All Studies; No Macitentan (Fixed)

Table 218. Meta-analysis Results of Six-Minute Walk Distance, Total Populations of All Studies (Random)

Table 219. Meta-analysis Results of Six-Minute Walk Distance, Total Populations of All Studies (Fixed)

Table 220. Meta-analysis Results of Six-Minute Walk Distance, Naive Populations of All Studies (Random)

Table 221. Meta-analysis Results of Six-Minute Walk Distance, Naive Populations of All Studies (Fixed)

Table 222. Meta-analysis Results of Clinical Worsening, Add-on to Endothelin Receptor Antagonist Pre-treated Populations (Random)

Table 223. Meta-analysis Results of Clinical Worsening, Add-on to Endothelin Receptor Antagonist Pre-treated Populations (Fixed)

Table 224. Meta-analysis Results of Functional Class Improvement, Add-on to Endothelin Receptor Antagonist Pre-treated Populations (Random)

Table 225. Meta-analysis Results of Functional Class Improvement, Add-on to Endothelin Receptor Antagonist Pre-treated Populations (Fixed)

Table 226. Meta-analysis Results of Functional Class Worsening, Add-on to Endothelin Receptor Antagonist Pre-treated Populations (Random)

Table 227. Meta-analysis Results of Functional Class Worsening, Add-on to Endothelin Receptor Antagonist Pre-treated Populations (Fixed)

Table 228. Meta-analysis Results Six-Minute Walk Distance, Add-on to Endothelin Receptor Antagonist Pre-treated Populations (Random)

Table 229. Meta-analysis Results of Six-Minute Walk Distance, Add-on to Endothelin Receptor Antagonist Pre-treated Populations (Fixed)

Copyright © 2015 CADTH.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK355850
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (9.4M)

Other titles in this collection

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...